Literature DB >> 2317957

Dual-energy CT-scan quantification of recalcification in osteolyses of the vertebral body due to mammary carcinomas in the course of antineoplastic treatment.

W Crone-Münzebrock1, U M Carl.   

Abstract

Recalcification of osteolyses can be determined by the use of dual-energy CT-scanning. Quantitative CT-scans have been performed in a group of 11 female patients with osteolytic metastatic spread of mammary carcinomas under systemic antineoplastic treatment. During their treatment with either chemotherapy or hormones these patients have been investigated every two weeks in a total observation period of three months. Additional to every CT-scan (n = 77) a conventional radiograph was taken. In the course of treatment it was possible to give reliable statements with regard to the response to therapy up to 8 weeks earlier by the use of quantitative CT-scans compared to conventional radiographs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317957     DOI: 10.1007/bf00117790

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  17 in total

1.  Management of advanced breast carcinoma; with special reference to combined radiation and hormone therapy.

Authors:  F C CHU; D W SVED; G C ESCHER; J J NICKSON; R PHILLIPS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1957-03

2.  Quantification of bone mineralization using computed tomography.

Authors:  P Rüegsegger; U Elsasser; M Anliker; H Gnehm; H Kind; A Prader
Journal:  Radiology       Date:  1976-10       Impact factor: 11.105

3.  Quantification of recalcification of irradiated vertebral body osteolyses by dual-energy computed tomography.

Authors:  W Crone-Münzebrock; R P Spielmann
Journal:  Eur J Radiol       Date:  1987-02       Impact factor: 3.528

4.  The predictive value of serial bone scans in assessing response to chemotherapy in advanced breast cancer.

Authors:  J D Bitran; C Bekerman; R K Desser
Journal:  Cancer       Date:  1980-04-01       Impact factor: 6.860

5.  Quantitative bone mineral analysis using dual energy computed tomography.

Authors:  H K Genant; D Boyd
Journal:  Invest Radiol       Date:  1977 Nov-Dec       Impact factor: 6.016

6.  Quantification of trabecular bone with low dose computed tomography.

Authors:  P Rüegsegger; M Anliker; M Dambacher
Journal:  J Comput Assist Tomogr       Date:  1981-06       Impact factor: 1.826

7.  Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging.

Authors:  B R Condon; R Buchanan; N W Garvie; D M Ackery; J Fleming; D Taylor; D Hawkes; B A Goddard
Journal:  Br J Radiol       Date:  1981-01       Impact factor: 3.039

8.  Dual-energy scanned projection radiography of osseous metastatic disease.

Authors:  D J Sartoris; F G Sommer; D A Oppenheimer
Journal:  Invest Radiol       Date:  1985-12       Impact factor: 6.016

9.  Single and dual energy tomographic analysis of spinal trabecular bone: a comparative study in normal and osteoporotic women.

Authors:  R Pacifici; N Susman; P L Carr; S J Birge; L V Avioli
Journal:  J Clin Endocrinol Metab       Date:  1987-02       Impact factor: 5.958

10.  Assessment of response to therapy in advanced breast cancer.

Authors:  J L Hayward; P P Carbone; J C Heusen; S Kumaoka; A Segaloff; R D Rubens
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

View more
  3 in total

Review 1.  Medical treatment of tumor-induced hypercalcemia and tumor-induced osteolysis: challenges for future research.

Authors:  J J Body
Journal:  Support Care Cancer       Date:  1993-01       Impact factor: 3.603

2.  Initial experience with dual-energy computed tomography-guided bone biopsies of bone lesions that are occult on monoenergetic CT.

Authors:  Michael C Burke; Ankur Garg; Jonathan M Youngner; Swati D Deshmukh; Imran M Omar
Journal:  Skeletal Radiol       Date:  2018-10-20       Impact factor: 2.199

3.  The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer.

Authors:  Jiasi Wang; Yanpeng Chu; Jie Li; Tingjie Wang; Liangli Sun; Pingfei Wang; Xiangdong Fang; Fanwei Zeng; Junfeng Wang; Fanxin Zeng
Journal:  PeerJ       Date:  2019-08-07       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.